0897.HK

Drug and healthcare products maker Wai Yuen Tong Medicine Holdings Ltd. (0897.HK) announced on Wednesday its revenue fell 5.8% year-on-year to HK$347 million ($45 million) in the six months to September. But its profit of HK$23.7 million was up 577% over the same period.

The big profit gain, even as revenue fell, owed mainly to fair value gains related to the company’s investment properties. At the same time, its net impairment losses on properties, plants and equipment were smaller than the same period last year.

Wai Yuen Tong said its sales for the six-month period fell by 7.3% year-on-year due to changes in consumption patterns among local residents and tourists. To counter such negative effects, the company launched new products under the Wai Yuen Tong brand, expanded cross-border e-commerce channels, and cooperated with celebrities and key opinion leaders to increase its visibility.

Wai Yuen Tong’s shares fell 0.4% in Thursday trade in Hong Kong.

By Lau Chi Hang

To subscribe to Bamboo Works weekly free newsletter, click  here

Recent Articles

Ele.me get rolled into Alibaba's e-commerce

Alibaba turns up its ‘instant retail’ game

The merger of its Ele.me service with its core e-commerce business marks a new stage in the e-commerce giant’s three-way “on-demand retail wars” with Meituan and JD.com Key Takeaways: Alibaba…
Chow Tai Fook issues first convertible bonds in 14 years: What does it see for the future?

Chow Tai Fook rediscovers gold in convertible bonds

The fundraising, even as the Hong Kong jeweler has sufficient financial resources to run its current operation, could hint at plans for its next growth phase Key Takeaways: Chow Tai…